|
| U.S. Brand
Names |
|
| Eurax®
Topical |

|
|
| Generic
Available |
|
|
No |

|
|
| Pharmacological Index |
|
|
Scabicidal Agent |

|
|
| Use |
|
|
Treatment of scabies ( Sarcoptes scabiei) and symptomatic treatment of
pruritus |

|
|
| Pregnancy Risk
Factor |
|
|
C |

|
|
| Contraindications |
|
|
Hypersensitivity to crotamiton or other components; patients who manifest a
primary irritation response to topical medications |

|
|
| Warnings/Precautions |
|
|
Avoid contact with face, eyes, mucous membranes, and urethral meatus; do not
apply to acutely inflamed or raw skin; for external use
only |

|
|
| Adverse
Reactions |
|
|
<1%: Local irritation, pruritus, contact dermatitis, warm
sensation |

|
|
| Overdosage/Toxicology |
|
|
Symptoms of ingestion include burning sensation in mouth, irritation of the
buccal, esophageal and gastric mucosa, nausea, vomiting and abdominal pain
There is no specific antidote; general measures to eliminate the drug and
reduce its absorption, combined with symptomatic treatment, are recommended
|

|
|
| Drug
Interactions |
|
|
No data reported |

|
|
| Mechanism of
Action |
|
|
Crotamiton has scabicidal activity against Sarcoptes scabiei;
mechanism of action unknown |

|
|
| Usual Dosage |
|
|
Topical:
Pruritus: Massage into affected areas until medication is completely
absorbed; repeat as necessary |

|
|
| Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
|
No information available to require special precautions |

|
|
| Dental Health:
Effects on Dental Treatment |
|
|
No effects or complications reported |

|
|
| Patient
Information |
|
|
For topical use only. Apply lotion to whole body from the chin down being
sure to cover all skin folds and creases. Apply a second application 24 hours
later. Avoid eyes. Take a bath 48 hours after application. All contaminated
clothing and bed linen should be washed to avoid reinfestation. If cure is not
achieved after 2 doses, use alternative therapy. Pregnancy/breast-feeding
precautions: Inform prescriber if you are or intend to be pregnant. Consult
prescriber if breast-feeding. |

|
|
| Nursing
Implications |
|
|
Lotion: Shake well before using; avoid contact with face, eyes, mucous
membranes, and urethral meatus |

|
|
| Dosage Forms |
|
|
Cream: 10% (60 g)
Lotion: 10% (60 mL, 454 mL) |

|
|
| References |
|
|
Eichenfield LF, Honig PJ, "Blistering Disorders in Childhood," Pediatr
Clin North Am, 1991, 38(4):959-76.
Hogan DJ, Schachner L, Tanglertsampan C,
"Diagnosis and Treatment of Childhood Scabies and Pediculosis," Pediatr Clin
North Am, 1991, 38(4):941-57.
|

|
|
Copyright © 2007 Drugs Area
|